ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

ALK^wt–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Mean red and green fluorescence intensity data from three experiments of cyanobacteria. by Emma T. Brentjens (17295999)

The <i>tax-4</i> mutant exhibits defects in increased body bending amplitude during locomotion after exposure to ketones, acetate esters, and tetrahydrofuran. by Masahiro Tomioka (430683)

Locomotion speed after exposure to organic solvents in <i>tax-4</i> and <i>osm-9</i> mutants. by Masahiro Tomioka (430683)

BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Requirement of D2R–RGS balance under various levels of [<i>DA</i>]_basal and [<i>DA</i>]_dip. by Hidetoshi Urakubo (578508)

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Amino acids interactions and binding energy describe that ABT-199 binds to ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

Parameter values for patches in the simulated landscape. by Miguel A. Acevedo (381283)

Table_1_High Anal Canal Pressure and Rectal Washouts Contribute to the Decrease of Anal Basal Pressure After Botulinum Toxin Injections in Paediatric Patients With Chronic Constipa... by Ge Sun (332789)

“…Their median age was 20.5 (7.75–53.25) months. Anal basal pressure decreased after injection in 20 cases. …”

Image_1_High Anal Canal Pressure and Rectal Washouts Contribute to the Decrease of Anal Basal Pressure After Botulinum Toxin Injections in Paediatric Patients With Chronic Constipa... by Ge Sun (332789)

“…Their median age was 20.5 (7.75–53.25) months. Anal basal pressure decreased after injection in 20 cases. …”

Image_2_High Anal Canal Pressure and Rectal Washouts Contribute to the Decrease of Anal Basal Pressure After Botulinum Toxin Injections in Paediatric Patients With Chronic Constipa... by Ge Sun (332789)

“…Their median age was 20.5 (7.75–53.25) months. Anal basal pressure decreased after injection in 20 cases. …”